L. Webster

发表

IN VITRO P-GLYCOPROTEIN INHIBITION ASSAYS FOR ASSESSMENT OF CLINICAL DRUG INTERACTION POTENTIAL OF NEW DRUG CANDIDATES: A RECOMMENDATION FOR PROBE SUBSTRATES

J. Polli, J. Rautio, J. Humphreys, 2006, Drug Metabolism and Disposition.

Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast–enhanced Magnetic Resonance Imaging

S. Lenhard, Richard T. Miller, L. Webster, 2016, Toxicologic pathology.

Rational use of in vitro P-glycoprotein assays in drug discovery.

J. Polli, L. Huang, J. Humphreys, 2001, The Journal of pharmacology and experimental therapeutics.

The systemic exposure of an N-methyl-D-aspartate receptor antagonist is limited in mice by the P-glycoprotein and breast cancer resistance protein efflux transporters.

Kelly H. Jordan, Joseph W Polli, Giovanni Vitulli, 2004, Drug metabolism and disposition: the biological fate of chemicals.

MULTIPLE MECHANISMS ARE INVOLVED IN THE BILIARY EXCRETION OF ACETAMINOPHEN SULFATE IN THE RAT: ROLE OF MRP2 AND BCRP1

K. Brouwer, K. Hoffmaster, J. Polli, 2005, Drug Metabolism and Disposition.

Temporal kinetics and concentration–response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes

W. Krol, L. Webster, Liangfu Chen, 2006, Journal of biochemical and molecular toxicology.